Cargando…
The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders
Recently, primary immune regulatory disorders have been described as a subset of inborn errors of immunity that are dominated by immune mediated pathology. As the pathophysiology of disease is elucidated, use of biologic modifiers have been increasingly used successfully to treat disease mediated cl...
Autores principales: | Arnold, Danielle E., Chellapandian, Deepak, Leiding, Jennifer W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264452/ https://www.ncbi.nlm.nih.gov/pubmed/34248986 http://dx.doi.org/10.3389/fimmu.2021.692219 |
Ejemplares similares
-
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
por: Chan, Alice Y., et al.
Publicado: (2020) -
Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders
por: Margarit-Soler, Adriana, et al.
Publicado: (2022) -
Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India
por: Raj, Revathi, et al.
Publicado: (2021) -
Hematopoietic Chimerism and Transplantation Tolerance: A Role for Regulatory T Cells
por: Pasquet, Lise, et al.
Publicado: (2011) -
Editorial: The role of hematopoietic and immune microenvironment in hematopoietic stem cell transplantation
por: Wang, Xiaoqi, et al.
Publicado: (2023)